Robert A. Olie

1.6k total citations
26 papers, 1.3k citations indexed

About

Robert A. Olie is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Robert A. Olie has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Oncology. Recurrent topics in Robert A. Olie's work include RNA Interference and Gene Delivery (8 papers), Cell death mechanisms and regulation (8 papers) and Multiple Myeloma Research and Treatments (6 papers). Robert A. Olie is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Cell death mechanisms and regulation (8 papers) and Multiple Myeloma Research and Treatments (6 papers). Robert A. Olie collaborates with scholars based in Switzerland, Netherlands and France. Robert A. Olie's co-authors include Uwe Zangemeister‐Wittke, Rolf A. Stahel, Siân H. Leech, Ana Paula Simões‐Wüst, Doriano Fabbro, Jonathan Hall, Oliver Gautschi, Pierre Golstein, Sophie Cornillon and Stefan Tschopp and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Current Biology.

In The Last Decade

Robert A. Olie

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Olie Switzerland 16 1.1k 361 153 120 113 26 1.3k
Sabine Schirm United States 16 891 0.8× 452 1.3× 161 1.1× 98 0.8× 93 0.8× 27 1.5k
Edwina C. Lerner United States 18 1.1k 1.0× 696 1.9× 213 1.4× 97 0.8× 82 0.7× 19 1.6k
Dieter Moosmayer Germany 19 977 0.9× 395 1.1× 281 1.8× 62 0.5× 38 0.3× 38 1.3k
John F. DeCoteau Canada 24 903 0.8× 401 1.1× 130 0.8× 168 1.4× 40 0.4× 63 1.5k
Bharvin K.R. Patel United States 17 623 0.6× 560 1.6× 259 1.7× 123 1.0× 57 0.5× 29 1.1k
Mala Mani United States 11 1.1k 1.0× 413 1.1× 132 0.9× 247 2.1× 57 0.5× 15 1.4k
Dale S. Haines United States 25 1.2k 1.1× 541 1.5× 130 0.8× 33 0.3× 40 0.4× 45 1.4k
Lakshmi Kasturi United States 12 1.3k 1.2× 522 1.4× 191 1.2× 41 0.3× 100 0.9× 14 1.9k
Willem den Besten United States 16 938 0.9× 418 1.2× 93 0.6× 159 1.3× 38 0.3× 20 1.2k
Doris A. Phelps United States 20 832 0.8× 362 1.0× 97 0.6× 61 0.5× 35 0.3× 36 1.3k

Countries citing papers authored by Robert A. Olie

Since Specialization
Citations

This map shows the geographic impact of Robert A. Olie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Olie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Olie more than expected).

Fields of papers citing papers by Robert A. Olie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Olie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Olie. The network helps show where Robert A. Olie may publish in the future.

Co-authorship network of co-authors of Robert A. Olie

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Olie. A scholar is included among the top collaborators of Robert A. Olie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Olie. Robert A. Olie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costa-García, Marcel, et al.. (2024). Optimized protocol for culturing menstrual blood-derived MSCs for combination with oncolytic adenoviruses in cancer treatment. PubMed. 32(4). 200907–200907. 1 indexed citations
2.
Oriol, Albert, et al.. (2014). Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study. Hematology. 20(7). 405–409. 11 indexed citations
3.
4.
Emmerich, B., A. von Rohr, Monika Engelhardt, et al.. (2008). Bortezomib Retreatment in Relapsed Multiple Myeloma (MM): Results from a Binational, Multicenter Retrospective Survey. Blood. 112(11). 2775–2775. 6 indexed citations
5.
Calderoni, Antonello, et al.. (2007). Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland. Swiss Medical Weekly. 137(2122). 317–322. 12 indexed citations
6.
Leech, Siân H., Robert A. Olie, & Uwe Zangemeister‐Wittke. (2003). Use of Antisense Oligonucleotides for Therapy: Manipulation of Apoptosis Inhibitors for Destruction of Lung Cancer Cells. Lung Cancer. 75. 655–670. 2 indexed citations
7.
Olie, Robert A., Jonathan Hall, François Natt, Rolf A. Stahel, & Uwe Zangemeister‐Wittke. (2002). Analysis of ribosyl-modified, mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1576(1-2). 101–109. 13 indexed citations
8.
Olie, Robert A., Christoph A. Hafner, Brigitte Sigrist, et al.. (2002). Bcl-2 and bcl-xL Antisense Oligonucleotides Induce Apoptosis in Melanoma Cells of Different Clinical Stages. Journal of Investigative Dermatology. 118(3). 505–512. 73 indexed citations
9.
10.
Gautschi, Oliver, Stefan Tschopp, Robert A. Olie, et al.. (2001). Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins. JNCI Journal of the National Cancer Institute. 93(6). 463–471. 124 indexed citations
11.
Olie, Robert A., Oliver Gautschi, Stefan Tschopp, et al.. (2000). Induction of apoptosis in lung-cancer cells followingbcl-xL anti-sense treatment. International Journal of Cancer. 86(4). 570–576. 77 indexed citations
12.
Stahel, Rolf A., Oliver Gautschi, Jonathan Hall, et al.. (2000). Antisense oligonucleotides targeting the expression of anti-apoptotic proteins in lung cancer cells. Lung Cancer. 29(1). 185–186. 1 indexed citations
13.
Simões‐Wüst, Ana Paula, Robert A. Olie, Oliver Gautschi, et al.. (2000). bcl-xl antisense treatment induces apoptosis in breast carcinoma cells. International Journal of Cancer. 87(4). 582–590. 54 indexed citations
14.
Cornillon, Sophie, Robert A. Olie, & Pierre Golstein. (1998). An insertional mutagenesis approach to Dictyostelium cell death. Cell Death and Differentiation. 5(5). 416–425. 24 indexed citations
15.
Olie, Robert A., Françoise Durrieu, Sophie Cornillon, et al.. (1998). Apparent caspase independence of programmed cell death in Dictyostelium. Current Biology. 8(17). 955–S1. 96 indexed citations
16.
Olie, Robert A., et al.. (1996). Apoptosis of human seminoma cells upon disruption of their microenvironment. British Journal of Cancer. 73(9). 1031–1036. 24 indexed citations
17.
Olie, Robert A., Leendert H. J. Looijenga, Lucie Boerrigter, et al.. (1995). N‐ and KRAS mutations in primary testicular germ cell tumors: Incidence and possible biological implications. Genes Chromosomes and Cancer. 12(2). 110–116. 37 indexed citations
18.
Olie, Robert A., et al.. (1995). Heterogeneity in the in vitro survival and proliferation of human seminoma cells. British Journal of Cancer. 71(1). 13–17. 19 indexed citations
19.
Looijenga, Leendert H. J., et al.. (1994). Seminomas of the canine testis. Counterpart of spermatocytic seminoma of men?. PubMed. 71(4). 490–6. 36 indexed citations
20.
Lier, F.L.J. van, et al.. (1992). Continuous β-galactosidase production with a recombinant baculovirus insect-cell system in bioreactors. Journal of Biotechnology. 22(3). 291–298. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Schirm Breakdown of academic impact, for papers by Edwina C. Lerner Breakdown of academic impact, for papers by Dieter Moosmayer Breakdown of academic impact, for papers by John F. DeCoteau Breakdown of academic impact, for papers by Bharvin K.R. Patel Breakdown of academic impact, for papers by Mala Mani Breakdown of academic impact, for papers by Dale S. Haines Breakdown of academic impact, for papers by Lakshmi Kasturi Breakdown of academic impact, for papers by Willem den Besten Breakdown of academic impact, for papers by Doris A. Phelps
Rankless by CCL
2026